Explore CRISPR QC’s latest news, resources, and insights that drive innovation and help achieve your research goals.
READ FULL ARTICLE HERE By Kiana Aran, PhD The adoption of CRISPR-Cas systems in therapeutics development has led to the...
CRISPR QC™ has announced that Toby Richardson, PhD has been appointed to the board of directors. READ FULL ARTICLE HERE...
The Clinical CRISPR Successes Are Stacking Up. But Where’s the Emphasis on Quality Control? In mid-September, Intellia released some promising...
How the CRISPR Tomato and Genome Editing is Shaping the Future of Agriculture One of the many applications of CRISPR-based...
The Missing Link in Pre-Clinical Genome Editing Workflows Currently, the “gold standard” genome editing workflows only produce one data type:...
Technology Driven Insights to Improve CRISPR Edit Outcomes READ THE FULL ARTICLE HERE SAN DIEGO–(BUSINESS WIRE)–On August 12, 2022, EvoNexus,...
© 2024 CRISPR QC™, Inc.
